Proteomics

Dataset Information

0

Identifying alterations post ILK inhibition in Meningioma cell lines


ABSTRACT: The current study reports alterations in PI3-Akt and Focal adhesion pathway post ILK inhibition in meningioma cell lines. The inhibition is done using a pyrazole that specifically inhibits Integrin Link Kinase. The global proteomic profile was analysed post treatment (24 hours) in treated vs untreated cell line replicates.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell

DISEASE(S): Brain Cancer

SUBMITTER: Shuvolina Mukherjee  

LAB HEAD: SANJEEVA SRIVASTAVA

PROVIDER: PXD014855 | Pride | 2021-09-08

REPOSITORIES: Pride

altmetric image

Publications

Comprehending Meningioma Signaling Cascades Using Multipronged Proteomics Approaches & Targeted Validation of Potential Markers.

Mukherjee Shuvolina S   Biswas Deeptarup D   Gadre Rucha R   Jain Pooja P   Syed Nelofer N   Stylianou Julianna J   Zeng Qingyu Q   Mahadevan Anita A   Epari Sridhar S   Shetty Prakash P   Moiyadi Aliasgar A   Roy Ball Graham G   Srivastava Sanjeeva S  

Frontiers in oncology 20200826


Meningiomas are one of the most prevalent primary brain tumors. Our study aims to obtain mechanistic insights of meningioma pathobiology using mass spectrometry-based label-free quantitative proteome analysis to identifying druggable targets and perturbed pathways for therapeutic intervention. Label-free based proteomics study was done from peptide samples of 21 patients and 8 non-tumor controls which were followed up with Phosphoproteomics to identify the kinases and phosphorylated components o  ...[more]

Similar Datasets

2014-03-06 | E-GEOD-55609 | biostudies-arrayexpress
2008-11-20 | E-GEOD-12530 | biostudies-arrayexpress
2022-03-30 | GSE168726 | GEO
2021-07-14 | GSE180061 | GEO
2008-11-21 | GSE12530 | GEO
2023-08-27 | MSV000092770 | MassIVE
| PRJNA746393 | ENA
| PRJNA713787 | ENA
2020-06-17 | GSE151067 | GEO
2023-09-06 | GSE221029 | GEO